Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. more
Time Frame | NARI | Sector | S&P500 |
---|---|---|---|
1-Week Return | -6.19% | -0.94% | -2.6% |
1-Month Return | 7.6% | -5.08% | -1.08% |
3-Month Return | 23.33% | -10.62% | 3.45% |
6-Month Return | 15.79% | -6.18% | 8.57% |
1-Year Return | -17.19% | 1.98% | 24.3% |
3-Year Return | -40.51% | -0.93% | 25.58% |
5-Year Return | 25.24% | 33.84% | 84.07% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 51.13M | 139.67M | 276.98M | 383.47M | 493.63M | [{"date":"2019-12-31","value":10.36,"profit":true},{"date":"2020-12-31","value":28.29,"profit":true},{"date":"2021-12-31","value":56.11,"profit":true},{"date":"2022-12-31","value":77.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 5.91M | 13.11M | 24.76M | 44.51M | 59.07M | [{"date":"2019-12-31","value":10.01,"profit":true},{"date":"2020-12-31","value":22.19,"profit":true},{"date":"2021-12-31","value":41.91,"profit":true},{"date":"2022-12-31","value":75.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 45.22M | 126.56M | 252.23M | 338.96M | 434.56M | [{"date":"2019-12-31","value":10.41,"profit":true},{"date":"2020-12-31","value":29.12,"profit":true},{"date":"2021-12-31","value":58.04,"profit":true},{"date":"2022-12-31","value":78,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 88.44% | 90.62% | 91.06% | 88.39% | 88.03% | [{"date":"2019-12-31","value":97.12,"profit":true},{"date":"2020-12-31","value":99.51,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.07,"profit":true},{"date":"2023-12-31","value":96.67,"profit":true}] |
Operating Expenses | 44.42M | 108.14M | 241.38M | 367.06M | 448.60M | [{"date":"2019-12-31","value":9.9,"profit":true},{"date":"2020-12-31","value":24.11,"profit":true},{"date":"2021-12-31","value":53.81,"profit":true},{"date":"2022-12-31","value":81.83,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 801.49K | 18.42M | 6.67M | (28.10M) | (14.03M) | [{"date":"2019-12-31","value":4.35,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":36.22,"profit":true},{"date":"2022-12-31","value":-152.55,"profit":false},{"date":"2023-12-31","value":-76.18,"profit":false}] |
Total Non-Operating Income/Expense | (2.82M) | (5.28M) | (300.00K) | 3.47M | 33.70M | [{"date":"2019-12-31","value":-8.38,"profit":false},{"date":"2020-12-31","value":-15.67,"profit":false},{"date":"2021-12-31","value":-0.89,"profit":false},{"date":"2022-12-31","value":10.3,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (1.19M) | 13.79M | 10.69M | (26.18M) | 4.25M | [{"date":"2019-12-31","value":-8.64,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":77.49,"profit":true},{"date":"2022-12-31","value":-189.9,"profit":false},{"date":"2023-12-31","value":30.79,"profit":true}] |
Income Taxes | 715.29K | (912.00K) | 845.00K | 3.08M | 5.88M | [{"date":"2019-12-31","value":12.16,"profit":true},{"date":"2020-12-31","value":-15.5,"profit":false},{"date":"2021-12-31","value":14.37,"profit":true},{"date":"2022-12-31","value":52.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (1.91M) | 14.70M | 9.84M | (29.27M) | (1.64M) | [{"date":"2019-12-31","value":-12.97,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":66.93,"profit":true},{"date":"2022-12-31","value":-199.08,"profit":false},{"date":"2023-12-31","value":-11.13,"profit":false}] |
Income From Continuous Operations | (1.19M) | 13.79M | 9.84M | (29.27M) | (1.64M) | [{"date":"2019-12-31","value":-8.64,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":71.36,"profit":true},{"date":"2022-12-31","value":-212.25,"profit":false},{"date":"2023-12-31","value":-11.86,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (1.91M) | 13.79M | 9.84M | (29.27M) | (1.64M) | [{"date":"2019-12-31","value":-13.83,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":71.36,"profit":true},{"date":"2022-12-31","value":-212.25,"profit":false},{"date":"2023-12-31","value":-11.86,"profit":false}] |
EPS (Diluted) | (0.02) | 0.07 | 0.16 | (0.55) | (0.03) | [{"date":"2019-12-31","value":-12.5,"profit":false},{"date":"2020-12-31","value":43.75,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-343.75,"profit":false},{"date":"2023-12-31","value":-18.75,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
NARI | |
---|---|
Cash Ratio | 0.75 |
Current Ratio | 1.77 |
Quick Ratio | 1.40 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
NARI | |
---|---|
ROA (LTM) | -3.21% |
ROE (LTM) | -17.72% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
NARI | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.38 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.62 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
NARI | |
---|---|
Trailing PE | NM |
Forward PE | 357.14 |
P/S (TTM) | 5.65 |
P/B | 7.47 |
Price/FCF | NM |
EV/R | 5.52 |
EV/Ebitda | 1575.18 |
Inari Medical Inc (NARI) share price today is $53.24
Yes, Indians can buy shares of Inari Medical Inc (NARI) on Vested. To buy Inari Medical Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NARI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Inari Medical Inc (NARI) via the Vested app. You can start investing in Inari Medical Inc (NARI) with a minimum investment of $1.
You can invest in shares of Inari Medical Inc (NARI) via Vested in three simple steps:
The 52-week high price of Inari Medical Inc (NARI) is $66.61. The 52-week low price of Inari Medical Inc (NARI) is $36.73.
The price-to-earnings (P/E) ratio of Inari Medical Inc (NARI) is
The price-to-book (P/B) ratio of Inari Medical Inc (NARI) is 7.47
The dividend yield of Inari Medical Inc (NARI) is 0.00%
The market capitalization of Inari Medical Inc (NARI) is $3.25B
The stock symbol (or ticker) of Inari Medical Inc is NARI